Established in 2015, Aziyo Biologics is a privately-held, commercially-oriented biotech company focused on regenerative medicine in areas such as cardiology, orthopedics and other medical specialties

Since its founding, the Company has expanded through a combination of acquisitions and strategic partnerships, creating a high-growth commercial entity. Our mission is to restore health and mobility through the development of innovative new solutions that expand the possibilities of regenerative medicine.

  • Proxicor for Cardiac Tissue Repair

    ProxiCor for Cardiac Tissue Repair is intended for use as an intracardiac patch or pledget for tissue repair (i.e. atrial septal defect [ASD], ventricular septal defect [VSD], etc.) and suture-line buttressing.

    See Product
  • CanGaroo

    The CanGaroo Envelope is intended to securely hold a cardiac implantable electronic device to create a stable environment when implanted in the body. The devices that may be used with the CanGaroo Envelope include pacemaker pulse generators, defibrillators, or other cardiac implantable electronic devices.

    See Product